“…Starting from a known ligand for a defined biological target, the replacement of a 12 C by its carbon-11 isotope allows identical biodistribution, and fluorine-18 can generally be introduced onto the original structure without significant change in the activity. − However, these approaches are lacking in modularity and often remain poorly compatible with highly functionalized biomolecules (i.e., peptides, oligonucleotides, etc.). Thus, last-step radiolabeling of biomolecule-based structures has emerged as a powerful strategy, , and various prosthetic groups have been designed aiming 18 F , or 11 C labeling. , In this last case, [ 11 C]CH 3 I, which is obtained in two steps from the cyclotron-produced [ 11 C]CO 2 , has been probably the most investigated 11 C-synthon . Simple alkylations on heteroatoms or more-advanced strategies based on cross-coupling reactions have been used, but chemo- and regioselectivity issues can occur when dealing with more-complex substrates.…”